Prazer Therapeutics was established with the core mission to help patients suffering from intractable diseases by using logical and innovative approaches to drug design.

We aim to accomplish this mission through our new and innovative drug development platforms, including rational molecular drug design technology and next-generation protein degradation technology.

Our hope is to challenge and overcome the current unmet medical needs through our platform technologies. We are willing to collaborate with all partners to achieve our goal: a healthy society without disease.

Making undruggable targets druggable, making incurable diseases curable.


Kyung-Soo Inn
CEOKyung-Soo Inn
Nam-Jung Kim
CSO (Chief Scientific Officer)Nam-Jung Kim
Jong-Kil Lee
CTO (Chief Technology Officer)Jong-Kil Lee
Jung-Jin Ahn
CFOJung-Jin Ahn

Scientific Advisors

Nam-Hyuk Cho
Seoul National UniversityNam-Hyuk Cho
Bum-Joon Kim
Seoul National UniversityBum-Joon Kim
Young-Taek Han
Dankook UniversityYoung-Taek Han


Company K partners
Company K partners
Kyung Hee University
Kyung Hee University
KITE Entrepreneurship Foundation
KITE Entrepreneurship Foundation